Store-operated Ca 2+ entry plays an important role in Ca 2+ homeostasis in cells but the mechanisms of control of these channels are not completely understood. We describe an investigation of the role of the CD38-cyclic-ADP-ribose (cADPR)-ryanodine-channel (RyR) signaling pathway in store-operated Ca 2+ entry in human smooth muscle. We observed that human myometrial cells have a functional storeoperated Ca 2+ entry mechanism. Furthermore, we observed the presence of transient receptor potential 1, 3, 4, 5, and 6 ion channels in human myometrial cells. Store-operated Ca 2+ transient was inhibited by at least 50-70% by several inhibitors of the RyR, including ryanodine (10 µM), dantrolene (10 µM), and ruthenium red (10 µM). Furthermore, the cell permeable inhibitor of the cADPR-system, 8-Br-cADPR (100 µM), is a potent inhibitor of the store-operated entry, decreasing the store operated entry by 80%. Pre-incubation of cells with 100 µM cADPR and the hydrolysis-resistant cADPR analog 3-deaza-cADPR (50 µM), but not with ADP-ribose (ADPR) leads to a 1.6-fold increase in the store-operated Ca 2+ transient. In addition, we observed that nicotinamide (1-10 mM), an inhibitor of cADPR synthesis, also leads to inhibition of the store-operated Ca 2+ transient by 50-80%. Finally, we observed that the transient receptor potential channels, RyR, and CD38 can be co-immunoprecipitated, indicating that they interact in vivo. Our observations clearly implicate the CD38-cADPR-ryanodine signaling pathway in the regulation of storeoperated Ca 2+ entry in human smooth muscle cells.
Introduction
The agonist-induced increase in intracellular free Ca 2+ concentration is an important component of several signaling pathways (1) . Two major mechanisms can increase cytosolic free Ca 2+ in cells, namely: a) release of Ca 2+ from intracellular stores, and b) influx of Ca 2+ from the extracellular media into the cell. It has been shown that agoniststimulated intracellular Ca 2+ transients are biphasic, with the initial, transient rise in Ca 2+ representing sarcoplasmic Ca 2+ release (1) (2) (3) (4) , and the later sustained Ca 2+ response representing predominantly Ca 2+ influx (1) (2) (3) (4) . One of the mechanisms of extracellular Ca 2+ influx is the so-called store-operated Ca 2+ entry (2) (3) (4) (5) . The store-operated Ca 2+ entry (also called capacitative Ca 2+ entry) appears to be mediated by a large family of channels called the transient receptor potential ion channels (TRPC; [2] [3] [4] [5] . In this process depletion of intracellular Ca 2+ stores leads to activation of channels located in the plasma membrane that are permeable to Ca 2+ (2) (3) (4) (5) . The mechanisms of activation of TRPCs by store depletion are not completely understood (2) (3) (4) (5) . Several intracellular signaling pathways have been implicated as regulators of the TRPCs, including the IP3, cAMP, and cGMP systems of second messengers (2-7). Cyclic-ADP-ribose (cADPR) is a calcium-mobilizing metabolite of ß-NAD. cADPR was initially described as a potent activator of the ryanodine receptor channel (RyR) and as an endogenous modulator of Ca 2+ release from intracellular stores (8) (9) (10) (11) (12) . Guse et al. (13) were the first to implicate cADPR as a potential activator of Ca 2+ entry in T-lymphocytes. More recently, it has been demonstrated that cADPR can also regulate the influx of extracellular Ca 2+ into neutrophils, suggesting a mechanism involving activation of store-operated Ca 2+ entry (14, 15) . However, whether cADPR is a modulator of store-operated Ca 2+ entry has not been completely elucidated. Recently, Kiselyov et al. (16, 17) described a direct interaction of the RyR with TRPC3. Furthermore, they reported that activation of the RyR leads to gating of the capacitative Ca 2+ entry (16, 17) . Because of the emerging importance of cADPR as a cellular modulator of Ca 2+ homeostasis, we explored the role of the CD38-cADPR-RyR signaling pathway in the activation of the store-operated Ca 2+ transient. We found that cADPR is an endogenous regulator of the store-operated Ca 2+ transient in human smooth muscle cells, and that TRPCs, RyR, and CD38 can be co-immunoprecipitated, suggesting that these proteins can interact in vivo.
Material and Methods

Cell preparation
Following Institutional Research Board approval, human myometrium was obtained from patients undergoing elective hysterectomy. Human myometrial cells were isolated using techniques previously described (18) . Briefly, the tissue was minced in Hanks' balanced salt solution (HBSS) containing 10 mM glucose and 10 mM HEPES, pH 7.4. The tissue was then suspended in fresh HBSS, aerated with 95% O 2 /5% CO 2 , and incubated in a 37ºC water bath with gentle shaking for 2 h in the presence of 20 U/mL papain and 2,000 U/mL DNase. Subsequently, the tissue was incubated for an additional 2 h at 37ºC, with the addition of 1 mg/mL type IV collagenase. Human myometrial cells were released by triturating and then centrifuged and suspended in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, 100 U/L penicillin, 100 µg/L streptomycin, and 2.5 µg/mL amphotericin B. Cultures were grown and maintained in 75-cm 2 plastic flasks in a humidified incubator supplied with 5% CO 2 /95% air at 37ºC. Subcultures were obtained as needed by detaching the cells with a Ca 2+ / Mg 2+ -free HBSS solution containing 0.25% trypsin and 5 mM EDTA. Only cultures between passages 2 and 10 were used. Cells isolated by this procedure stain positive for smooth muscle actin and negative for keratin. For the experiments, cells were made quiescent by replacing the growth medium with DMEM without serum. Cell medium was again replaced with DMEM containing testing agents solubilized in 0.1% DMSO or water at the appropriate final concentrations.
Fura 2 loading and [Ca 2+ ]i measurements
Human myometrial smooth muscle cells were plated onto 8-chambered Lab-Teks plates (Nalge Nunc International Corp., Naperville, IL, USA) at a density of 25,000 cells/well and grown until approximately 80% confluence in DMEM. Cells were then washed in HBSS and medium was replaced with DMEM lacking serum for 24 h. Cells were then incubated with 5 µM Fura 2/AM and test agents for 60 min at 37ºC and washed 3X with HBSS containing 1 mM MgSO 4 /not containing CaCl 2 . The Lab-Teks plate was then transferred to an inverted Nikon Diaphot microscope equipped with a Princeton Instrument RTE/CCD 12-bit digital camera (Trenton, NJ, USA) controlled through a PC workstation and feed inlets and vacuum outlets for solution changes. A Nikon 20X/0.75 objective lens was used and image size was set to 720 x 540 pixels. A fluorescent light excited the cells alternatively at 340 and 380 nm with a Lambda 10 filter wheel (Sutter Instruments, Novato, CA, USA). Emitted fluorescence (510 nm) was acquired for 100 ms at each excitation wavelength. Cells were perfused for 2 min with HBSS containing 2 mM calcium followed by 4 min of perfusion with HBSS not containing calcium. Subsequently, the cells were perfused with HBSS not containing calcium, 1 µM nifedipine and HBSS not containing calcium, 1 µM nifedipine, and 10 µM cyclopiazonic acid (CPA) for 4 min each. Finally, cells were perfused with HBSS containing 2 mM calcium, 1 µM nifedipine, and 10 µM CPA. Influx of calcium was determined using Metamorph software (Jandel Scientific, Santa Barbara, CA, USA) and averaging changes in fluorescent ratio of 50 individual cells by the following equation: [Ca 2+ ] = Kd*(Fmin/Fmax)*((Rvisc*Rmin)/(visc*Rmax-R)), where Kd is the apparent dissociation constant (224 nM at room temperature), F stands for fluorescence at 380 nm, and R for the ratio at 340/ 389 nm. Fmin and Rmin are the measurements in the absence of Ca 2+ , and Fmax and Rmax are the fluorescent values at 380 nm and 340/380 nm ratios in saturating Ca 2+ , R is equivalent to the ratio of fluorescent intensity at 340/380 nm minus the background, and visc is the viscosity value of the cytoplasm (visc = 1). Alternatively, cells were seeded onto 9 x 22-mm coverslips and grown as previously described. When cells were approximately 80% confluent, coverslips were loaded with Fura 2/AM, rinsed in HBSS not containing CaCl 2 and placed in the thermostated cuvette (25ºC) of a Hitachi F-2000 fluorescence spectrophotometer. Cells were then monitored as previously described and results determined by comparing the 340/380-nm wavelength ratio.
Immunoprecipitation and Western blot
Human myometrial cells were rinsed twice with HBSS, harvested and subjected to sonication (3 x 5 s) in radio-immunoprecipitation assay (RIPA) homogenizing buffer containing 1 µmol/L PMSF. The homogenates were centrifuged at 10,000 g for 10 min and the resultant supernatant was assayed for protein using the DC protein assay (BioRad, Hercules, CA, USA). The lysates (200 µL) were adjusted to contain 200 µg protein and 2 µg mouse monoclonal anti-CD38 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit polyclonal anti-RyR (Santa Cruz Biotechnology), or rabbit polyclonal anti-TRPC antibody (Alomone Labs, Jerusalem, Israel) added overnight at 4 o C with gentle rocking. The antibody-protein complex was then immunoprecipitated for 2 h using Protein A/G Plus-Agarose (Santa Cruz Biotechnology), the pellet was washed twice in RIPA buffer, and resuspended in 30 µL RIPA buffer and 30 µL Laemmli buffer. The supernatants were denatured at 100ºC for 3-5 min and 40 µL of the sample subjected to SDS-PAGE using the Criterion Gel System (BioRad) and a 4-15% gradient gel. The gels were run at a constant current of 200 V for 70 min followed by transfer to PVDF membranes (BioRad). The membranes were blocked for 1 h in 5% nonfat dry milk in Tris-buffered saline (TBS) containing 0.1% Tween 20 followed by incubation with appropriate primary antibodies and horseradish-peroxidase-conjugated secondary antibody or horseradish-peroxidase-linked Protein A. Blots were then visualized by exposing them to BioMax MR film (Eastman Kodak Co., Rochester, NY, USA) using LumiGLO (Cell Signaling Technology, Beverly, MA, USA). The specificity of the immunoprecipitation was determined by the use of non-specific IgG (Santa Cruz Biotechnology) in control experiments.
Immunocytochemistry of transient receptor potential channels
Cells were grown on 8-chambered LabTeks plates as described, fixed in 2% paraformaldehyde, rinsed three times in TBS and blocked in 10% donkey serum for 1 h at room temperature with gentle shaking. The blocking solution was aspirated and rabbit polyclonal anti-TRPC antibody diluted 1:200 in 5% donkey serum added overnight at 4ºC with gentle rocking. Following the incubation period, chambers were aspirated, rinsed three times in TBS and donkey anti-rabbit CY3-linked secondary antibody (Sigma, St. Louis, MO, USA) diluted 1:200 in TBS was added for 3 h at room temperature with gentle shaking. Cells were rinsed three times in TBS, dried and visualized with an Olympus confocal microscope using Fluoview version 2.0 software.
Material
Fura 2/AM was purchased from Calbiochem (San Diego, CA, USA). 3-DeazacADPR was purchased from Molecular Probes (Eugene, OR, USA). All other reagents, of the highest purity grade available, were supplied by Sigma.
The experiments were repeated 3-6 times and data are reported as mean ± SEM. The unpaired t-test was used to establish statistical significance, with P values <0.05 considered to be significant.
Results
Role of cADPR in agonist-stimulated Ca 2+ transients
We have demonstrated that human smooth muscle cells utilize the CD38/cADPR pathway to modulate [Ca 2+ ]i transients during agonist stimulation (18) . The components of this pathway are present and functional in myometrial, vascular and airway smooth muscle cells (18) (19) (20) (21) (22) (23) (24) . One important observation is the fact that the intracellular Ca 2+ transients induced by oxytocin are dependent on both the CD38/cADPR signaling pathway and extracellular Ca 2+ in human myometrial cells. Stimulation of myometrial cells with oxytocin, vasopressin and endothelin-1 leads to [Ca 2+ ]i responses that are largely dependent on influx of extracellular Ca 2+ , whereas responses to bradykinin or histamine are not (Figure 1 ). An interesting Figure 1 . Role of cADPR on agonist stimulated Ca 2+ transients. Human myometrial smooth muscle cells were grown as described in the Material and Methods section on 9 x 22-mm coverslips. Cells were then incubated with 8-Br-cADPR (100 µM) or vehicle (controls and 0 mM Ca 2+ ) for 60 min, the coverslips were rinsed with HBSS containing 2 or 0 mM Ca 2+ and the calcium transients measured with the stated agonists (final concentrations = 1 µM for oxytocin (Oxy), vasopressin (AVP), and endothelin-1 (ET-1); 10 nM for bradykinin (BK), and 10 µM for histamine (Hist)). CTL = control. Data are reported as percentage of control and are the means ± SEM of four independent experiments. The treatment of cells with 8-BrcADPR or not containing Ca 2+ (0 mM Ca 2+ ) led to a significant decrease of the oxytocin-, vasopressin-and endothelin-induced Ca 2+ transients. These treatments had no significant effect on the Ca 2+ release induced by bradykinin or histamine. observation is that agonist responses that are dependent on extracellular Ca 2+ , i.e., oxytocin, vasopressin and endothelin-1, are also significantly inhibited by 8-Br-cADPR, a cell permeant antagonist of the cADPR signaling pathway, and the level of inhibition is similar to levels observed in the absence of extracellular Ca 2+ (Figure 1 ). An equally intriguing observation is that the responses to bradykinin or histamine, which are largely independent on Ca 2+ influx, are attenuated by 8-Br-cADPR to a much lesser extent and again the attenuation mimics the effects of zero extracellular Ca 2+ (Figure 1 ). These results clearly implicate the CD38/cADPR signaling pathway in agonist-induced Ca 2+ responses involving Ca 2+ influx, as 8-BrcADPR significantly attenuates those responses primarily dependent on Ca 2+ influx.
Store-operated Ca 2+ transients in human smooth muscle cells
A significant amount of Ca 2+ influx in smooth muscle cells is mediated by storeoperated Ca 2+ entry (25) (26) (27) . First, we examined whether myometrial cells contain a functional store-operated Ca 2+ entry pathway. Store-operated Ca 2+ entry can be evoked in cells by depletion of intracellular Ca 2+ stores, namely the sarcoplasmic reticulum (SR) in smooth muscle cells. Using CPA or thapsigargin (Tg), inhibitors of the SR Ca 2+ ATPase, to deplete the stores we found that human smooth muscle cells have a functional store-operated Ca 2+ transient pathway (Figure 2A and data not shown) . The Ca 2+ influx stimulated by depletion of intracellular stores was not inhibited by 1 µM nifedipine (an inhibitor of the L-type Ca 2+ channels). Furthermore, CPA-and Tg-induced Ca 2+ transients were completely blocked by the store-operated Ca 2+ entry inhibitors 100 µM 2-APB and 1 mM Gd 3+ ( Figure 2B ) and the relatively non-specific cation channel blockers 1 mM La 3+ , 1 mM Ni 2+ , and 10 µM SKF-96365 (data not shown). These data indicate that human smooth muscle cells exhibit functional store-operated Ca 2+ entry. Next, we determined the expression of TRPCs on human smooth muscle cells. In agreement with previously published data we observed that several isoforms of TRPCs are expressed in human smooth muscle cells (26, 27) . We observed expression of TRPC1, 3, 4, 5, and 6 protein in myometrial cells by immunohistochemistry (Figure 3) . In summary, these data demonstrate that transient receptor potential channels are expressed and that a Ca 2+ influx pathway typical of store-operated Ca 2+ entry is present in human myometrial cells.
Role of the RyR in the store-operated Ca 2+ transient pathway in human smooth muscle cells
The mechanisms regulating the activity of the store-operated Ca 2+ entry have not been completely elucidated. One possibility is that intracellular Ca 2+ channels and signaling pathways are coupled to the activation of TRPCs resulting in store-operated Ca 2+ entry. In fact, both IP3 and the RyR have been implicated as modulators of the gating properties of TRPCs (5, 16, 17) . It has been previ- Figure 2 . Characterization of store-operated calcium transients in human myometrial smooth muscle cells. Influx of calcium was measured as described in the Material and Methods section. A, Human myometrial cells were perfused with HBSS containing 0 mM Ca 2+ for 4 min with or without CPA (10 µM) followed by perfusion with HBSS containing 2 mM Ca 2+ . Influx of calcium in cells not perfused with CPA was 95% less than cells perfused with CPA (6 vs 122 nM Ca 2+ , respectively). The figure is representative of three different experiments. B, Cells were grown on 9 x 22-mm coverslips, loaded with 5 µM Fura 2-AM, rinsed briefly in HBSS containing 0 mM Ca 2+ and the coverslips placed in a cuvette with calcium-free HBSS. Cells were then treated with or without CPA (10 µM), 2-APB (100 µM), Gd 3+ (1 mM), or nifedipine (1 µM final concentrations). Results are reported as percentage of control and are representative of three to five independent experiments. CTL = control; CPA = cyclopiazonic acid; 2-APB = 2-aminoethoxydiphenyl borate; Gd 3+ = gadolinium. ously shown that the RyR co-immunoprecipitates with TRPC3 (16, 17) , and that activation of the RyR leads to gating of the TRPC (16, 17) . In fact, it has been proposed previously that coupling between the RyR and store-operated Ca 2+ entry is important for the modulation of this Ca 2+ influx pathway (16, 17) .
We have shown that human smooth muscle cells have functional RyR (18) . Here we explored the role of the RyR in CPAstimulated store-operated Ca 2+ transients. We found that inhibition of the activity of RyRs using three different structurally unrelated RyR inhibitors, namely ruthenium red, dantrolene, and ryanodine, leads to a significant decrease in CPA-induced store-operated Ca 2+ transients ( Figure 4B ). These data indicate that modulation of the activity of RyRs mediates store-operated Ca 2+ entry in human myometrial cells. Inhibition of store-operated Ca 2+ transients by RyR inhibition is likely due to gating of TRPCs as opposed to decreased SR depletion, as we also observed that CPA-and Tg-induced intracellular Ca 2+ store depletion was not altered by the RyR inhibitors used in this study. Next we examined whether coupling of RyRs and storeoperated Ca 2+ transients may involve a direct association of RyRs with TRPCs. Immunoprecipitation of TRPCs and the subsequent immunoblotting for the RyR revealed co-immunoprecipitation of the RyR with TRPC3 and TRPC5 ( Figure 4A ). Combined, these data imply a coupling of RyRs with the store-operated Ca 2+ entry pathway possibly via direct interaction with TRPCs.
Role of cADPR in store-operated Ca 2+ entry cADPR has recently emerged as a second messenger mediating Ca 2+ homeostasis in a variety of cell types by acting as an endogenous modulator of the RyR (8) (9) (10) (11) (12) . We have shown that cADPR is important for agonist-stimulated Ca 2+ transients in smooth muscle cells (18) (19) (20) (21) . Since RyR activity appears to be important for the gating of the store-operated Ca 2+ entry channels and A, Cell extracts were prepared in RIPA buffer, proteins adjusted to 200 µg/vial and 2 µg rabbit polyclonal anti-TRPC antibodies added overnight. The antibodyprotein complex was then immunoprecipitated using Protein A/ G-agarose, the pellet washed, resuspended in Laemmli buffer, and the sample separated by SDS-PAGE (4-15% gel) using standard protocols. The proteins were transferred to a PVDF membrane and the RyR detected using a rabbit polyclonal antibody. Results indicate bands >250 kDa associated with TRPC3 and 5 and weakly with TRPC4 immunoprecipitates. The arrow indicates the molecular mass of RyR. The figure is representative of three different experiments. B, Human myometrial smooth muscle cells were grown in 8-chambered LabTeks plates, incubated for 60 min with antagonists (10 µM each) or vehicle (controls), loaded with Fura 2-AM and store-operated calcium transient was measured. All test agents inhibited store-operated Ca 2+ transients (ruthenium red = -70%, dantrolene = -48%, ryanodine = -77%) compared to controls. Data are reported as means ± SEM for at least three independent experiments. *P < 0.05 compared to control (unpaired t-test). cADPR is an endogenous regulator of RyR activity, we explored the role of this nucleotide on the store operated Ca 2+ entry pathway. Using a cell-permeable cADPR antagonist, 8-Br-cADPR, we determined that cADPR modulates both CPA-and Tg-stimulated store-operated Ca 2+ transients ( Figure  5A ). We observed that 8-Br-cADPR dosedependently inhibits the store-operated Ca 2+ transient ( Figure 5A, inset) . Recently, Bolotina and colleagues (27) have demonstrated that calmidazolium (CMZ) activates the store-operated Ca 2+ influx pathway through a mechanism involving phospholipase A2. This mechanism leads to the generation of lysophospholipids which then triggers store-operated Ca 2+ channels. We examined whether CMZ activates store-operated Ca 2+ transients in human myometrial cells. CMZ treatment enhanced store-operated Ca 2+ transients and this enhancement was significantly inhibited by 8-Br-cADPR ( Figure 5B ). This would suggest that cADPR modulates store-operated Ca 2+ via a mechanism upstream of phospholipase A2 (27) . In addition, we observed that pre-incubation of human myometrial cells with cADPR or the hydrolysis-resistant cADPR agonist, 3-deaza-cADPR, leads to more than a 50% increase in CPA-induced store-operated Ca 2+ transients ( Figure 6B ). In contrast, the cADPR metabolite ADPR had no effect on store-operated Ca 2+ transients ( Figure 6B ). Next, we used an inhibitor of cADPR synthesis, nicotinamide, to determine the role of endogenous synthesis of this nucleotide in the activity of store-operated Ca 2+ transients. We found that pre-incubation of cells with nicotinamide leads to a significant dosedependent inhibition of CPA-stimulated store-operated Ca 2+ transients ( Figure 6A ). Finally, we explored the possibility of a direct association of CD38, the enzyme responsible for cADPR synthesis, with TRPCs by co-immunoprecipitation studies. Immunoprecipitation of TRPC1, 3, 4, 5, and 6 with the subsequent Western blotting for CD38 revealed that CD38 was co-immunoprecipi- tated with all of the TRPC family members examined ( Figure 7 ). In agreement with this observation, immunoprecipitation of CD38 followed by probing for the TRPC isoforms also revealed tight association of CD38 with the various TRPC isoforms (Figure 8 ). These data demonstrate a role for the CD38/cADPR signaling pathway in modulating store-operated Ca 2+ entry in human myometrial cells and suggest a mechanism involving the coupling of TRPCs to all of the players in the CD38/cADPR signaling pathway.
M. Thompson et al. Figure 6 . Effect of nicotinamide and cADPR on store-operated Ca 2+ . A, Nicotinamide was incubated for 60 min with human myometrial smooth muscle cells grown in 8-chambered Lab-Teks plates prior to measuring the storeoperated calcium transient, as described in the Material and Methods section. Concentrations of 5 mM (-27%) and 10 mM (-57%) nicotinamide produced significant inhibition in comparison to controls (P < 0.05, paired t-test). B, ADPR, cADPR, and 3-deaza-cADPR were incubated for 60 min with cells followed by measurement of storeoperated Ca 2+ transient. cADPR (100 µM) and 3-deaza-cADPR (50 µM) produced a significant (P < 0.05, compared to control, unpaired t-test) stimulation of store-operated Ca 2+ transients compared to control. ADPR had no significant effect. Data are reported as means ± SEM of three independent experiments and are reported as percentage of controls. cADPR = cyclic-ADP-ribose. Figure 7 . Co-immunoprecipitation of CD38 with the transient receptor protein channels (TRPC). Cell extracts were prepared in RIPA buffer and immunoprecipitated with a rabbit polyclonal anti-TRPC antibody as previously described. The resultant antibody-protein complex was electrophoresed and transferred to a PVDF membrane as described in the Material and Methods section. The blot was then probed with a mouse monoclonal anti-CD38 antibody and the film developed following incubation with a horse radish peroxidase-linked secondary donkey antimouse antibody. A ~50-kDa band corresponding to CD38 was associated with TRPC1, 3, 4, 5, and 6 immunoprecipitates. Control experiments were performed as above using a non-specific (NS) rabbit polyclonal IgG antibody which produced no corresponding 50-kDa band. Data are representative of 3-5 experiments. Non-specific IgG IP myometrial cells, our observation that cADPR can modulate store-operated Ca 2+ entry appears to apply to other cell types, since 8-Br-cADPR can also inhibit the storeoperated Ca 2+ in HL-60 cells by 82%. We conclude that cADPR is a regulator not only of Ca 2+ release from intracellular stores mediated by the RyR, but also of the mechanisms of extracellular Ca 2+ influx mediated by the TRPCs. This regulation appears to be mediated by a direct interaction between the components of the cADPR-CD38-RyR pathway and the TRPCs. A similar interaction between the inositol 1,4,5-triphosphate system and the store-operated Ca 2+ entry pathway has been proposed (5). It is possible that the crosstalk between intracellular channels and the plasma membrane may play an important role in the mechanism of replacement of intracellular Ca 2+ stores.
